Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank75
Studio
Year-over-Year Change

Interest expense on outstanding debt

Percentile
P75
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4072.00+100.1%
2024$-4.34M-364.1%
2023$1.64M-
2022$0.00-
2021$0.00-